Laurion Capital Management LP Scholar Rock Holding Corp Transaction History

Laurion Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$7.84 - $16.79 $2.43 Million - $5.21 Million	-310,084 Reduced 59.06%	214,972 $1.79 Million
Q1 2024 May 15, 2024	BUY	$13.2 - $17.76 $962,412 - $1.29 Million	72,910 Added 16.13%	525,056 $9.32 Million
Q4 2023 Feb 14, 2024	SELL	$6.52 - $20.32 $558,451 - $1.74 Million	-85,652 Reduced 15.93%	452,146 $8.5 Million
Q2 2023 Aug 14, 2023	SELL	$5.79 - $9.11 $92,072 - $144,867	-15,902 Reduced 2.87%	537,798 $4.05 Million
Q3 2022 Nov 14, 2022	SELL	$5.33 - $11.3 $45,209 - $95,846	-8,482 Reduced 1.51%	553,700 $3.84 Million
Q2 2022 Aug 15, 2022	BUY	$4.66 - $13.96 $2.62 Million - $7.85 Million	562,182 New	562,182 $3.09 Million
Q4 2018 Feb 14, 2019	SELL	$17.86 - $28.77 $267,900 - $431,550	-15,000 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$15.0 - $25.6 $225,000 - $384,000	15,000 New	15,000 $234,000

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.17B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.